Chart of the Day: Novo Nordisk - All Time High

The Chart of the Day belongs to the Danish healthcare company Novo Nordisk (NVO)  .  I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature to review the charts for consistent price appreciation. 

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 20 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart Technical Indicators:

• 100% technical buy signals
• 44.22+Weighted Alpha
• 33.83% gain in the last year
• Trend Seeker buy signal
• Above its 20, 50 and 100 day moving averages
• 7 new highs and up 3.12% in the last month
• Relative Strength Index 61.10%
• Recently traded at $146.69 with 50 day moving average of $140.41.

Fundamental Factors:

• Market Cap $333 billion
• P/E 41.38
• Dividend yield .55%
• Revenue expected to grow 17.80% this year and another 13.50% next year
• Earnings are estimated to increase 32.70% this year and an additional 10.90% next year and continue to compound at an annual rate of 2.80% for the next 5 years

Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:

• Wall Street analysts issued 5 strong buy, 1 hold and 2 sell opinions on the stock
• Their price targets are $115 to $176
• The individual investors following the stock on Motley Fool vote 712 to 24 for he stock to beat the market with the more experienced investors voting 156 to 4 for the same result
• Value Line give it its highest rating of 1 and has a consensus price target of 174 about 20% above today's close
• 48,670 investors monitor the stock on Seeking Alpha

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in  the next 72 hours.

Additional disclosure: The Barchart Chart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance and reevaluate your stop losses at least on a weekly basis.